|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02211 UNI HEALTH
Nominal 
0.550 -0.010 (-1.786%) | 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 266,824 | -39.517% | 711,509 | 1,089,037 | 1,297,036 | 1,273,572 |
| Cost of Sales | (219,376) | -40.836% | (598,122) | (909,152) | (1,083,190) | (1,069,410) |
| Gross Profit | 47,448 | -32.567% | 113,387 | 179,885 | 213,846 | 204,162 |
| 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (6,901) | (4,157) | (10,098) | (21,579) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 658 | 1,733 | (20,959) | (1,625) | |
| Profit / (Loss) before Taxation | (5,150) | -12.519% | (22,940) | (2,792) | (112,105) | (188,013) | |
| Taxation | (908) | -49.359% | (2,734) | 3,372 | 5,990 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | (332) | (167) | 718 | 366 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (6,058) | -24.388% | (26,006) | 413 | (105,397) | (187,647) | |
| 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,744 | -- | (1,941) | 4,607 | (7,278) | (2,322) |
| Depreciation & Amortisation | 6,733 | -2.051% | 13,710 | 14,030 | 16,235 | 26,055 |
| Directors' Emoluments | -- | -- | 1,970 | 2,025 | 2,388 | 2,675 |
| 2025/12 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | -6.210 | -37.900% | -32.460 | 0.620 | -180.700 | -426.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.746) | (1.522) | (0.031) | (0.096) |
| NBV per share ($) | 3.094 | -- | 3.964 | 4.403 | 4.714676 | 7.336641 |
| Remarks: | Real time quote last updated: 05/03/2026 16:16 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -6,058 |
| %Change | -24.388% |
| EPS / (LPS) | RMB -0.062 |
| NBV Per Share (¥) | RMB 3.094 |